Antifungal drug use in transplant patients − is it optimal?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.623, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Pediatric Patients with Hyperlipidemia Receive Drug Therapy?

By Bhatnagar D.

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite

Hepatotoxicity in patients taking rosiglitazone: is it drug-induced?

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Caution needed for empiric use of vancomycin in paediatric patients?

Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Stratified care optimal for migraine?

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Does Package Design Matter for Patients?: The Association Between Package Design and Patients' Drug Knowledge

By Wilke Thomas

Pharmaceutical Medicine, Vol. 25, Iss. 5, 2011-10 ,pp. : 307-317

Adis International

Access to resources Recommend Favorite